News

Medtronic, GOLD AF Registry, PVAC GOLD, atrial fibrillation, ablation catheter

Medtronic plc announced the first patient enrollment in the GOLD AF Registry, a prospective, observational clinical study of its Phased Radiofrequency (RF) Ablation technology for treating...

catheter ablation, Afib, Amiodarone, Luigi Di Biase, ACC, heart failure

Patients with heart failure and atrial fibrillation were less likely to experience death, hospitalization or recurrent Afib with catheter ablation than with a heart rhythm-regulating drug,...

atients with atrial fibrillation (AF) who received ablation while they were already undergoing surgery to...

CTSN, atrial fibrillation, surgical ablation, mitral valve surgery

New study results from The Cardiothoracic Surgical Trials Network (CTSN) show the addition of surgical ablation during mitral valve surgery reduces the occurrence of atrial fibrillation in...

Ablation system, atrial fibrillation, Medtronic Arctic Front Advance Cryoballoon

Medtronic announced the initiation of the Cryo4 Persistent AF (Cryoballoon Ablation for Early Persistent Atrial Fibrillation) clinical trial.

Ablation Catheters, Atrial Fibrillation, EP Lab, FlexAbility Ablation Catheter

St. Jude Medical Inc. announced U.S. Food and Drug Administration (FDA) approval of the FlexAbility Ablation Catheter, a new ablation technology used by electrophysiologists for the treatment of...

St. Jude, STAR-VT, ventricular tachycardia, ablation catheter, FlexAbility

St. Jude Medical Inc. announced the first patient enrollment in the STAR-VT (Substrate Targeted Ablation using the FlexAbility Ablation...

CardioFocus, HeartLight Endoscopic Ablation System, Japan Lifeline, distribution

CardioFocus Inc., developer of the HeartLight Endoscopic Ablation System for the treatment of atrial fibrillation (AF), announced that it has executed an exclusive, multi-year distribution...

Ablation Systems, Atrial Fibrillation, EP Lab, Clinical Trial/Study

Medtronic, Inc. announced the initiation of a randomized clinical trial in Europe to assess the benefits of ablation using the Medtronic Artic Front Advance cryoballoon as a first-line treatment...

atrial fibrillation, FDA, Dual Epicardial and Endocardial Procedure, DEEP

Enrollment is open for the Dual Epicardial and Endocardial Procedure (DEEP) clinical trial following U.S Food and Drug Administration Approval (FDA). 

New physician experience for the Convergent Procedure in the treatment of persistent atrial fibrillation (AF) was presented during a podium talk at the Northeast Cardiothoracic Surgical Society...

Topera, Abbott, FIRMap, rotors, rotor mapping

Abbott has entered into an agreement to purchase Topera Inc., a private, venture-backed medical device company focused on developing electrophysiology technologies to improve the diagnosis and...

St. Jude Medical Inc. today announced U.S. Food and Drug Administration (FDA) approval of its TactiCath Quartz irrigated ablation catheter, which gives physicians a real-time, objective measure of...

Imricor Medical Systems, Inc. announced the first three cardiac ablation procedures were completed in the first clinical study that is evaluating the feasibility of their magnetic resonance (MR)-...

October 15, 2014 — AtriCure, Inc. today announced enrollment in the ABLATE Post Approval Study (PAS) is complete.

topera, catheter, FIRMmap

John Muir Health's Concord medical center is the first hospital in Northern California and one of just 20 hospitals in the nation to begin treating patients who suffer from atrial fibrillation (...

A clinical trial being conducted at Mission Health on a special catheter could one day help people with a persistent heart condition that does not respond to medication.

July 31, 2014 — Radiation therapy may offer a promising new noninvasive alternative treatment for the millions of Americans whose high blood pressure doesn’t respond to medication, suggests...

July 30, 2014 — St. Jude Medical announced CE mark approval and first use of the FlexAbility ablation catheter, a novel ablation technology used by electrophysiologists (EPs) for the treatment of...

A new physician poster presentation at the Atrial Fibrillation Symposium 19th Annual International Meeting in Orlando, Fla., reports long-term outcomes for the convergent procedure, a...